I'll thank him for that the next time we're having a beer, hopefully.
I don't have that figure at hand, but, undoubtedly, the basic and increasingly early translational work for pharmaceuticals and advanced medicinal therapies draws heavily on public dollars. I think the COVID vaccines are a fantastic example of how a great deal of investment from the public sector was then picked up to take through phase three trials, which the pharmaceutical industry are absolutely astoundingly good at, but it takes both. The proportions vary a lot.
I'm sorry. That's not a helpful answer.